Dokter Providas: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dokter Providas
Largest movements
- Current investments +€300,000
new in 2025: €300,000
- Cash -€212,071
down €212,071 (-36.4%), from €582,710 to €370,640
mainly Current investments (-€300,000) and Contributions, distributions and other (-€54,000)
- Reserves +€85,660
up €85,660 (+13.4%), from €639,160 to €724,820
- Gross operating margin +€27,509
up €27,509 (+15.3%), from €179,995 to €207,504
- Taxes +€9,962
up €9,962 (+19.2%), from €51,783 to €61,745
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €667,493 | €756,278 | +€88,785 | +13.3% |
| Fixed assets | 21/28 | €8,724 | €7,048 | -€1,676 | -19.2% |
| Tangible fixed assets | 22/27 | €8,724 | €7,048 | -€1,676 | -19.2% |
| Plant, machinery and equipment | 23 | €4,910 | €3,857 | -€1,053 | -21.4% |
| Furniture and vehicles | 24 | €3,815 | €478 | -€3,336 | -87.5% |
| Other tangible fixed assets | 26 | - | €2,713 | +€2,713 | |
| Current assets | 29/58 | €658,768 | €749,230 | +€90,462 | +13.7% |
| Amounts receivable after more than one year | 29 | €65,000 | €65,000 | = | 0.0% |
| Other amounts receivable | 291 | €65,000 | €65,000 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €11,058 | €13,591 | +€2,532 | +22.9% |
| Other amounts receivable | 41 | €11,058 | €13,591 | +€2,532 | +22.9% |
| Current investments | 50/53 | - | €300,000 | +€300,000 | |
| Cash at bank and in hand | 54/58 | €582,710 | €370,640 | -€212,071 | -36.4% |
| Total equity and liabilities | 10/49 | €667,493 | €756,278 | +€88,785 | +13.3% |
| Equity | 10/15 | €658,467 | €744,135 | +€85,668 | +13.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €639,160 | €724,820 | +€85,660 | +13.4% |
| Distributable reserves | 133 | €639,160 | €724,820 | +€85,660 | +13.4% |
| Profit (loss) carried forward | 14 | €707 | €715 | +€8 | +1.2% |
| Amounts payable | 17/49 | €9,026 | €12,143 | +€3,117 | +34.5% |
| Amounts payable within one year | 42/48 | €9,026 | €12,143 | +€3,117 | +34.5% |
| Trade debts | 44 | €2,943 | €398 | -€2,545 | -86.5% |
| Suppliers | 440/4 | €2,943 | €398 | -€2,545 | -86.5% |
| Taxes, remuneration and social security | 45 | €6,083 | €11,745 | +€5,662 | +93.1% |
| Taxes | 450/3 | €6,083 | €11,745 | +€5,662 | +93.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,805 | €4,399 | +€594 | +15.6% |
| Other operating charges | 640/8 | €1,317 | €918 | -€399 | -30.3% |
| Gross operating margin | 9900 | €179,995 | €207,504 | +€27,509 | +15.3% |
| Operating profit (loss) | 9901 | €174,873 | €202,187 | +€27,314 | +15.6% |
| Financial income | 75/76B | €0 | €8 | +€8 | |
| Recurring financial income | 75 | €0 | €8 | +€8 | |
| Financial charges | 65/66B | €408 | €781 | +€373 | +91.6% |
| Recurring financial charges | 65 | €408 | €781 | +€373 | +91.6% |
| Profit (loss) for the period before taxes | 9903 | €174,465 | €201,413 | +€26,948 | +15.4% |
| Income taxes | 67/77 | €51,783 | €61,745 | +€9,962 | +19.2% |
| Profit (loss) for the period | 9904 | €122,682 | €139,668 | +€16,986 | +13.8% |
| Profit (loss) for the period to be appropriated | 9905 | €122,682 | €139,668 | +€16,986 | +13.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.